Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michelle M. Rohde"'
Autor:
Kevin M. Cockroft, Einar Bogason, Michelle M. Rohde, Gayle Watson, Jessica M. Vesek, Susan J. Pazuchanics
Publikováno v:
Journal of Radiology Nursing. 32:58-65
Over recent years, there have been dramatic advances in the ability to treat an acute ischemic stroke. Thrombolysis with intravenous recombinant tissue plasminogen activator can now be performed up to 4.5 hr after stroke onset in certain circumstance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48b89fdcaea6eb48338395b04ede92a
https://doi.org/10.1016/j.jradnu.2012.11.003
https://doi.org/10.1016/j.jradnu.2012.11.003
Autor:
Pan Y; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Rohde M; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Zeitler J; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Namburi SVS; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Cao L; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Hu J; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Meyer K; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA., Lu Y; Sangamo Therapeutics, Inc, 7000 Marina Boulevard, Brisbane, CA 94005, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Oct 10; Vol. 31, pp. 101126. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).
Autor:
Ou L; Gene Therapy Center, University of Minnesota, Minneapolis, MN, USA., DeKelver RC; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Rohde M; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Tom S; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Radeke R; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., St Martin SJ; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Santiago Y; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Sproul S; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Przybilla MJ; Center for Genome Engineering, Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., Koniar BL; Research Animal Resources, University of Minnesota, Minneapolis, MN, USA., Podetz-Pedersen KM; Center for Genome Engineering, Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., Laoharawee K; Center for Genome Engineering, Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., Cooksley RD; Gene Therapy Center, University of Minnesota, Minneapolis, MN, USA., Meyer KE; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Holmes MC; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., McIvor RS; Center for Genome Engineering, Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., Wechsler T; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Whitley CB; Gene Therapy Center, University of Minnesota, Minneapolis, MN, USA. Electronic address: whitley@umn.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2019 Jan 02; Vol. 27 (1), pp. 178-187. Date of Electronic Publication: 2018 Nov 01.
Autor:
Laoharawee K; Center for Genome Engineering, Department of Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., DeKelver RC; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Podetz-Pedersen KM; Center for Genome Engineering, Department of Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., Rohde M; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Sproul S; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Nguyen HO; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Nguyen T; Center for Genome Engineering, Department of Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA., St Martin SJ; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Ou L; Gene Therapy Center, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Tom S; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Radeke R; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Meyer KE; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Holmes MC; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., Whitley CB; Gene Therapy Center, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Wechsler T; Sangamo Therapeutics, Inc., 501 Canal Boulevard, Richmond, CA, USA., McIvor RS; Center for Genome Engineering, Department of Genetics Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA. Electronic address: mcivo001@umn.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2018 Apr 04; Vol. 26 (4), pp. 1127-1136. Date of Electronic Publication: 2018 Mar 10.